AMIA applauds CMS's efforts to reduce documentation burden

The American Medical Informatics Association (AMIA) is thanking the Centers for Medicare & Medicaid Services (CMS) for its work to reduce physicians’ documentation burden and encourage the use of health IT for patient care.

According to a press release, the organization recently submitted comments to the CMS applauding its proposals to align physician and hospital electronic health record (EHR) requirements, advance policies that encourage the adoption of health IT for patient care and reduce documentation burden for physicians through Evaluation & Management (E&M) reform.

In its comments, the organization said “there was ‘great promise’ in the use of passive ‘behind the scenes’ data collection, facilitated through EHRs and other health IT to both reduce clinical documentation burden and improve billing precision."

The organization also encouraged CMS to "support their proposed E&M reforms with focused and well-resourced efforts to leverage these current functions and develop emerging functions, such as natural language processing, medical device data, voice recognition software, and the use of sensors to capture clinical activity.”

To read the AMIA’s entire comments, click the link below.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.